Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors
Open Access
- 13 January 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-11
Abstract
Angiotensin-converting enzyme inhibitors are widely used for treatment of hypertension and related diseases. Here, six karnamicins E1-E6 (1–6), which bear fully substituted hydroxypyridine and thiazole moieties are characterized from the rare actinobacterium Lechevalieria rhizosphaerae NEAU-A2. Through a combination of isotopic labeling, genome mining, and enzymatic characterization studies, the programmed assembly of the fully substituted hydroxypyridine moiety in karnamicin is proposed to be due to sequential operation of a hybrid polyketide synthase-nonribosomal peptide synthetase, two regioselective pyridine ring flavoprotein hydroxylases, and a methyltransferase. Based on AlphaFold protein structures predictions, molecular docking, and site-directed mutagenesis, we find that two pyridine hydroxylases deploy active site residues distinct from other flavoprotein monooxygenases to direct the chemo- and regioselective hydroxylation of the pyridine nucleus. Pleasingly, karnamicins show significant angiotensin-converting enzyme inhibitory activity with IC50 values ranging from 0.24 to 5.81 μM, suggesting their potential use for the treatment of hypertension and related diseases.Keywords
Funding Information
- National Natural Science Foundation of China (22107014, 82225043)
This publication has 51 references indexed in Scilit:
- Angiotensin-Converting Enzyme InhibitorsThe Journal of Clinical Hypertension, 2011
- Structure of the PLP Degradative Enzyme 2-Methyl-3-hydroxypyridine-5-carboxylic Acid Oxygenase from Mesorhizobium loti MAFF303099 and Its Mechanistic ImplicationsBiochemistry, 2009
- Structure of 2,6-Dihydroxypyridine 3-hydroxylase from a Nicotine-degrading PathwayJournal of Molecular Biology, 2008
- Flavoprotein monooxygenases, a diverse class of oxidative biocatalystsJournal of Biotechnology, 2006
- Signaling by the Angiotensin-Converting EnzymeCirculation Research, 2006
- Portability of Oxidase Domains in Nonribosomal Peptide Synthetase ModulesBiochemistry, 2004
- Substrate Recognition by “Password” in p-Hydroxybenzoate HydroxylaseBiochemistry, 1999
- Identification of a novel conserved sequence motif in flavoprotein hydroxylases with a putative dual function in FAD/NAD(P)H bindingProtein Science, 1997
- The Mobile Flavin of 4-OH Benzoate HydroxylaseScience, 1994
- LisinoprilDrugs, 1988